American Brain Tumor Association’s Running Program Recruiting for 2018 Chicago Marathon

Printer Friendly

October 31, 2017

CHICAGO – As an official Bank of America Chicago Marathon Charity Partner, the American Brain Tumor Association (ABTA) is recruiting runners to join the Team Breakthrough endurance program by November 30, 2017 and guarantee entry for the 2018 Chicago Marathon.

The ABTA’s Team Breakthrough consists of caregivers, family and friends, medical professionals, brain tumor community supporters, and brain tumor survivors, like three-time Team Breakthrough member Rob Arnold.

“My third brain surgery was one week after the 2016 marathon, and to be honest, I didn’t think I would run again – I was so worried about my post-surgical functioning,” Arnold said. “Believe it or not, my recovery was quick, and I knew it was due to my endurance which I gained from running.”

Arnold and 90 other impressive runners completed the 2017 Chicago Marathon and raised more than $125,000. The money raised supports the ABTA’s mission to advance the understanding and treatment of brain tumors with the goals of improving, extending and, ultimately, saving the lives of those impacted by a brain tumor diagnosis.

Running enthusiasts are invited to register today to secure a guaranteed spot with the ABTA’s Team Breakthrough. In addition to marathon entry, Team Breakthrough runners receive a personal fundraising web page, a Team Breakthrough running shirt, a pasta luncheon, a pre and post-marathon party, and gear check near Start/Finish on race day.

To learn more or to guarantee entry for the 2018 Chicago Marathon, visit or contact Kali Drews at or 773-577-8761.

About Team Breakthrough
Team Breakthrough is the ABTA’s endurance training program, which allows runners of all levels – from beginner to more advance – to participate in nationwide endurance events while raising awareness and funds for brain tumor research and programs for those impacted by a brain tumor diagnosis.

About the American Brain Tumor Association 
Founded in 1973, the American Brain Tumor Association was the first national patient advocacy organization committed to funding brain tumor research and providing support and education programs for people of all tumor types and all ages. For more information, visit or call 800-886-ABTA (2282).


Media Contact:
Rachael Goniu